请登录
搜索 英文站
栏目

提醒成功

请输入手机号/邮箱号
请输入密码

账号密码登录

微信/QQ登录 微信/QQ登录

没有账号? 立即注册

搜索
Rabbit Polyclonal Antibody to BCL-2(Ab-70)
Western blot analysis of extracts from MCF cells using BCL-2(Ab-70) Antibody P41288 and the same antibody preincubated with blocking peptide.
Rabbit Polyclonal Antibody to BCL-2(Ab-70)
Immunofluorescence staining of methanol-fixed Hela cells using BCL-2(Ab-70) Antibody P41288.
Rabbit Polyclonal Antibody to BCL-2(Ab-70)
Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue using BCL-2(Ab-70) Antibody P41288(left) or the same antibody preincubated with blocking peptide(right).
Rabbit Polyclonal Antibody to BCL-2(Ab-70)
Rabbit Polyclonal Antibody to BCL-2(Ab-70)
Rabbit Polyclonal Antibody to BCL-2(Ab-70)

Rabbit Polyclonal Antibody to BCL-2(Ab-70)

  • 货号:

    P41288
  • 别名:

    BCL2
  • 产品上架时间:

    2024-01-01
  • 应用:

    WB,IHC,IF
  • 反应种属:

    Human
  • 抗体类型:

    Primary antibody
  • Swissprot:

    P10415
  • 规格:

  • 数量:

    -
    +
  • 说明书:

    目录价¥1980

加入购物车

Rabbit Polyclonal Antibody to BCL-2(Ab-70)

Description

BCL-2 encodes an integral outer mitochondrial membrane protein that blocks the apoptotic death of some cells such as lymphocytes. Constitutive expression of BCL2, such as in the case of translocation of BCL2 to Ig heavy chain locus, is thought to be the cause of follicular lymphoma. Two transcript variants, produced by alternate splicing, differ in their C-terminal ends.

References

Muller IM, et al. (2005) Mol Pharmacol.Jin Z, Gao F,et al. J Biol Chem 2004 Sep 17; 279(38): 40209-19.Kumar Biswas S,et al. Mol Cancer Ther 2004 Mar; 3(3): 327-34.Huang ST,et al. (2002)FASEB J; 16(8): 825-32.Yamamoto K,et al. (1999) Mol Cell Biol; 19(12): 8469-78.

Specification

Aliases BCL2
Entrez GeneID 596;
Swissprot P10415
WB Predicted band size 26kDa
Host/Isotype Rabbit IgG
Antibody Type Primary antibody
Storage Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species Reactivity Human
Immunogen Peptide sequence around aa.68~72 (R-T-S-P-L) derived from Human BCL-2.
Formulation Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Application

WB 1/500-1/1000
IHC 1/50-1/100
IF/ICC 1/100-1/200